The benzodiazepine inverse agonist RO19-4603 exerts prolonged and selective suppression of ethanol intake in alcohol-preferring (P) rats. 1994

H L June, and J M Murphy, and J J Mellor-Burke, and L Lumeng, and T K Li
Department of Psychology, Purdue School of Science, Indiana University-Purdue University, Indianapolis 46202.

The time course of the benzodiazepine (BDZ) inverse agonist RO19-4603 in antagonizing ethanol (EtOH) intake was investigated in alcohol-preferring (P) rats (n = 7) maintained on 24-h continuous free-choice access to EtOH (10% v/v), water, and food. After fluid intakes had stabilized over several weeks, animals were injected with Tween-80 vehicle solution or RO19-4603 (0.075, 0.150, and 0.30 mg/kg). EtOH and water intakes were determined at 8- and 24-h intervals. RO19-4603 caused a marked attenuation of EtOH drinking with each of the doses tested. EtOH intake during the 8-h following 0.075, 0.150, and 0.30 mg/kg RO19-4603 was decreased by approximately 36, 74, and 57%, respectively. Intakes during the 24-h interval were similar to the vehicle control condition. However, 32 h post-drug administration, EtOH intakes were reduced to approximately 27, 31, and 29% following the 0.075, 0.150 and 0.30 mg/kg doses, respectively. To further confirm the reliability of the RO19-4603 dose-response effect, and its selectivity for EtOH, the highest dose condition (0.30 mg/kg) was tested twice. The second 0.30 mg/kg dose condition exerted a profile of effects similar to the initial treatment; 8 h following administration, intake was decreased to 60% of the control level, and 32 h post-drug administration intake was decreased to approximately 46% of the controls. These decreases were evidently selective in comparison with water, since water drinking showed compensatory increases which paralleled the decreased EtOH consumption. Dose-response comparisons indicated that 0.150 mg/kg approaches the maximum effective dose, since the 0.30 mg/kg dose of RO19-4603 did not produce an additional decrease in EtOH intake.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004326 Drinking The consumption of liquids. Water Consumption,Water Intake,Drinkings
D005260 Female Females
D000427 Alcohol Deterrents Substances interfering with the metabolism of ethyl alcohol, causing unpleasant side effects thought to discourage the drinking of alcoholic beverages. Alcohol deterrents are used in the treatment of alcoholism. Deterrents, Alcohol
D000428 Alcohol Drinking Behaviors associated with the ingesting of ALCOHOLIC BEVERAGES, including social drinking. Alcohol Consumption,Alcohol Intake,Drinking, Alcohol,Alcohol Drinking Habits,Alcohol Drinking Habit,Alcohol Intakes,Consumption, Alcohol,Drinking Habit, Alcohol,Habit, Alcohol Drinking,Habits, Alcohol Drinking,Intake, Alcohol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001381 Azepines Seven membered heterocyclic rings containing a NITROGEN atom. Hexamethyleneimines
D012201 Reward An object or a situation that can serve to reinforce a response, to satisfy a motive, or to afford pleasure. Rewards
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D058785 GABA-A Receptor Agonists Endogenous compounds and drugs that bind to and activate GABA-A RECEPTORS. GABA-A Agonists,GABA-A Receptor Agonist,Agonist, GABA-A Receptor,Agonists, GABA-A,Agonists, GABA-A Receptor,GABA A Agonists,GABA A Receptor Agonist,GABA A Receptor Agonists,Receptor Agonist, GABA-A,Receptor Agonists, GABA-A

Related Publications

H L June, and J M Murphy, and J J Mellor-Burke, and L Lumeng, and T K Li
October 1994, Naunyn-Schmiedeberg's archives of pharmacology,
H L June, and J M Murphy, and J J Mellor-Burke, and L Lumeng, and T K Li
April 2011, Developmental psychobiology,
H L June, and J M Murphy, and J J Mellor-Burke, and L Lumeng, and T K Li
January 1990, Alcohol and alcoholism (Oxford, Oxfordshire),
H L June, and J M Murphy, and J J Mellor-Burke, and L Lumeng, and T K Li
January 1985, Alcohol (Fayetteville, N.Y.),
H L June, and J M Murphy, and J J Mellor-Burke, and L Lumeng, and T K Li
September 1995, Pharmacology, biochemistry, and behavior,
H L June, and J M Murphy, and J J Mellor-Burke, and L Lumeng, and T K Li
October 2005, Brain research,
H L June, and J M Murphy, and J J Mellor-Burke, and L Lumeng, and T K Li
January 1990, Alcohol (Fayetteville, N.Y.),
H L June, and J M Murphy, and J J Mellor-Burke, and L Lumeng, and T K Li
September 1994, European journal of pharmacology,
H L June, and J M Murphy, and J J Mellor-Burke, and L Lumeng, and T K Li
October 2014, Pharmacology, biochemistry, and behavior,
H L June, and J M Murphy, and J J Mellor-Burke, and L Lumeng, and T K Li
January 1986, Alcohol (Fayetteville, N.Y.),
Copied contents to your clipboard!